Clinical Trial Update: The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 trial evaluated the effect of melatonin on post-acute withdrawal in males in a residential treatment program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Substance Withdrawal Syndrome

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Duquesne University | Conditions: Substance Withdrawal Syndrome | Phase 1, Phase 2 | Status: COMPLETED